Psychedelic Mad Men: 5 Questions for public health researcher Olivia Marcus

Psychedelic advertising is reshaping how psychedelic treatments are presented to consumers, and Olivia Marcus argues it is largely following the same legacy playbook as pharmaceutical marketing. Marcus, a public health researcher and medical anthropologist, traces how marketing language evolved from early ayahuasca retreat promotions (with extreme healing claims and spiritual framing) to modern, algorithm-driven direct-to-consumer ads using templated websites and familiar health-ad imagery. She highlights repeating buzzwords and themes such as trauma and PTSD recovery, burnout and stuckness, breakthrough and empowerment, and “going to the root,” noting how these promises can outpace evidence and function as behavioral targeting. Marcus also connects psychedelic ads to broader ethical concerns about direct-to-consumer promotion, arguing that social media advertising can be especially toxic when it normalizes potentially potent substances like ketamine through unboxing-style messaging and minimal risk communication. Overall, she predicts continued “race to the bottom” dynamics as psychedelic services seek growth and normalization, with wellness and pharma-style claims increasingly converging unless priorities change.